Adicet Bio, Inc.
ACETFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Adicet Bio, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 9 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 23, 2026. The latest institutional report shown is dated Mar 31, 2019; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Federation des caisses Desjardins du Quebec | 2019-03-31 | 400 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2018-12-31 | 400 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2018-09-30 | 400 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2018-06-30 | 400 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2018-03-31 | 400 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2017-12-31 | 650 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2017-09-30 | 650 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2017-06-30 | 7,368 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2017-03-31 | 17,729 | Not shown | SEC filing |
- Each value is checked against Adicet Bio, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 9 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Federation des caisses Desjardins du Quebec: 400 shares reported 2018-12-31; 400 shares reported 2019-03-31.
- Federation des caisses Desjardins du Quebec: 400 shares reported 2018-09-30; 400 shares reported 2018-12-31.
- Federation des caisses Desjardins du Quebec: 400 shares reported 2018-06-30; 400 shares reported 2018-09-30.
- Federation des caisses Desjardins du Quebec: 400 shares reported 2018-03-31; 400 shares reported 2018-06-30.
- Federation des caisses Desjardins du Quebec: 650 shares reported 2017-12-31; 400 shares reported 2018-03-31.
- Federation des caisses Desjardins du Quebec: 650 shares reported 2017-09-30; 650 shares reported 2017-12-31.
- Federation des caisses Desjardins du Quebec: 7,368 shares reported 2017-06-30; 650 shares reported 2017-09-30.
- Federation des caisses Desjardins du Quebec: 17,729 shares reported 2017-03-31; 7,368 shares reported 2017-06-30.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Adicet Bio, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-10-08 · ORBIMED ADVISORS LLC: Larger than all 21 other insider purchases of Common Stock on file. SEC filing
- 2024-01-25 · GORDON CARL L: Larger than 19 of the 21 other insider purchases of Common Stock on file. SEC filing
- 2024-01-25 · ORBIMED ADVISORS LLC: Larger than 19 of the 21 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2024-01-25–2024-01-25: 6 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
- 2023-06-27–2023-06-30: 9 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-04-08 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | S — Open market or private sale | −40,416 | 6.52 | SEC filing |
| 2026-04-08 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | S — Open market or private sale | −32,523 | 6.29 | SEC filing |
| 2026-04-07 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | S — Open market or private sale | −29,319 | 6.53 | SEC filing |
| 2026-04-07 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | S — Open market or private sale | −2,400 | 6.38 | SEC filing |
| 2026-02-20 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | P — Open market or private purchase | +74,751 | 7.27 | SEC filing |
| 2026-02-19 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | P — Open market or private purchase | +74,268 | 7.21 | SEC filing |
| 2026-02-18 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | P — Open market or private purchase | +74,577 | 7.04 | SEC filing |
| 2025-10-08 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | P — Open market or private purchase | +1,500,000 | 1.00 | SEC filing |
Showing 8 of 17 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-21 | Grissinger Michael · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +4,200 | SEC filing |
| 2026-06-21 | Chodakewitz Jeffrey · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +4,200 | SEC filing |
| 2026-06-21 | DUBIN STEVE · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +4,200 | SEC filing |
| 2026-06-21 | Klickstein Lloyd · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +4,200 | SEC filing |
| 2026-06-21 | Peng Katie · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +4,200 | SEC filing |
| 2026-06-21 | Sinclair Andrew · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +4,200 | SEC filing |
| 2026-06-19 | Schor Chen · President & CEO | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +55,000 | SEC filing |
| 2026-06-19 | Aftab Blake · Chief Scientific Officer | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +55,000 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-27 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | J — Other acquisition or disposition | −250,000 | SEC filing |
| 2026-04-27 | RA Capital Healthcare Fund LP · 10% owner | Pre-Funded Warrant (Right to Buy) | J — Other acquisition or disposition | +250,000 | SEC filing |
| 2024-08-21 | Sinclair Andrew · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −18,500 | SEC filing |
| 2024-08-21 | Sinclair Andrew · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −26,400 | SEC filing |
| 2024-08-21 | DUBIN STEVE · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −18,500 | SEC filing |
| 2024-08-21 | GORDON CARL L · Director, 10% owner | Stock Option (Right to Buy) | D — Disposition to the issuer | −26,400 | SEC filing |
| 2024-08-21 | Chodakewitz Jeffrey · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −18,500 | SEC filing |
| 2024-08-21 | GORDON CARL L · Director, 10% owner | Stock Option (Right to Buy) | D — Disposition to the issuer | −18,500 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.